# 2022 International Conference on Gram Positive Pathogens

> **NIH NIH R13** · UNIVERSITY OF ILLINOIS AT CHICAGO · 2022 · $7,000

## Abstract

Project Summary
The International Conference on Gram-Positive Pathogens (ICGPP) brings together scientists at all stages of
their careers to exchange ideas and research strategies stemming from shared interests in gram-positive
pathogens. This conference, initially held in 2006 and then continued in 2008, 2010, 2012, 2014, 2016, and 2018
because of participant enthusiasm, grew out of collaborations between investigators at the University of
Nebraska Medical Center and other academic institutions in the great plains region of the United States. The
overarching benefit of ICGPP is the opportunity for investigators to share the science, approaches, and protocols
that are unique to gram-positive bacteria in contrast to gram-negative bacteria. While gram-positive pathogens
cause myriad infections, ranging from antibiotic-associated colitis to necrotizing fasciitis, fundamental aspects of
biological function such as protein secretion across single membranes, cell wall biosynthesis and protein
anchoring, and cell-cell communication are shared between this group of medically important bacteria. The
impact of gram-positive infections continues to grow, and antibiotic resistance remains a significant threat. As
an example, Clostridioides difficile enterocolitis, once primarily associated with antibiotic use in hospitals, is now
found in young, healthy adults that do not have an epidemiological relationship to a healthcare facility. Recent
data suggests that infections caused by C. difficile are the leading cause of mortality among antibiotic-resistant
bacteria in the US. In addition, community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)
strain USA300 continues to cause skin and soft tissue infections in schools, locker rooms, and hospitals in
otherwise healthy individuals. This R13 application is requesting funds to support the 8th ICGPP to be held
October 9 -12, 2022 in Omaha, Nebraska. Our diverse organizing and scientific committee comprises ten
principal investigators from various academic institutions representing the full range of medically relevant gram-
positive bacteria. Although other meetings exist in the US that cover various aspects of bacterial pathogenesis
or prokaryotic biology, this is the only meeting focused specifically on gram-positive pathogenesis and biology,
and which provides a collegial and supportive environment that fosters interactions between established
investigators and junior scientists. Young scientists have the option of presenting their research in either poster
or oral format and, in 2018, out of the 27 non-keynote speakers, 17 trainees and 8 Assistant Professors gave
oral research presentations. Four internationally known scientists have already agreed to give keynote
presentations at the 2022 ICGPP: Drs. Andreas Peschel (University of Tubingen), Drusilla Burns (U.S. Food and
Drug Administration), Shonna McBride (Emory University) and Jose Lemos (University of Florida). To keep
registration fees low ...

## Key facts

- **NIH application ID:** 10539629
- **Project number:** 1R13AI172268-01
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT CHICAGO
- **Principal Investigator:** Francis Alonzo
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $7,000
- **Award type:** 1
- **Project period:** 2022-09-01 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10539629

## Citation

> US National Institutes of Health, RePORTER application 10539629, 2022 International Conference on Gram Positive Pathogens (1R13AI172268-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10539629. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*